| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| vitamin D3 receptor isoform VDRA | 10 | 0 | 0 | 10 |
| TDP1 protein | 19 | 0 | 0 | 19 |
| AR protein | 21 | 0 | 0 | 21 |
| glucocorticoid receptor [Homo sapiens] | 18 | 0 | 0 | 18 |
| estrogen nuclear receptor alpha | 22 | 0 | 0 | 22 |
| peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
| ATP-binding cassette sub-family C member 3 | 0 | 8 | 0 | 8 |
| Multidrug resistance-associated protein 4 | 0 | 8 | 0 | 11 |
| Bile salt export pump | 0 | 14 | 0 | 14 |
| Cellular tumor antigen p53 | 15 | 0 | 0 | 15 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
| Prostacyclin receptor | 0 | 4 | 2 | 6 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 4 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
| Canalicular multispecific organic anion transporter 1 | 0 | 8 | 0 | 8 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 4 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 3A1 | 0 | 0 | 0 | 1 |
| Chain A, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain B, HADH2 protein | 4 | 0 | 0 | 4 |
| Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
| Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
| Chain A, Cruzipain | 8 | 0 | 0 | 8 |
| DNA topoisomerase | 0 | 1 | 0 | 1 |
| thioredoxin reductase | 8 | 0 | 0 | 8 |
| 15-lipoxygenase, partial | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 10 | 0 | 0 | 10 |
| Fumarate hydratase | 3 | 0 | 0 | 3 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| PPM1D protein | 3 | 0 | 0 | 3 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 15 | 0 | 0 | 15 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| thyroid stimulating hormone receptor | 5 | 0 | 0 | 5 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| EWS/FLI fusion protein | 6 | 0 | 0 | 6 |
| estrogen-related nuclear receptor alpha | 18 | 0 | 0 | 18 |
| polyprotein | 3 | 0 | 0 | 3 |
| 67.9K protein | 5 | 0 | 0 | 5 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 12 | 0 | 0 | 12 |
| Bloom syndrome protein isoform 1 | 4 | 0 | 0 | 4 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
| hemoglobin subunit beta | 2 | 0 | 0 | 2 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
| chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 9 | 0 | 0 | 9 |
| huntingtin isoform 2 | 5 | 0 | 0 | 5 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| DNA polymerase iota isoform a (long) | 7 | 0 | 0 | 7 |
| nuclear receptor ROR-gamma isoform 1 | 9 | 0 | 0 | 9 |
| geminin | 18 | 0 | 0 | 18 |
| survival motor neuron protein isoform d | 9 | 0 | 0 | 9 |
| cytochrome P450 3A4 isoform 1 | 5 | 0 | 0 | 5 |
| M-phase phosphoprotein 8 | 3 | 0 | 0 | 3 |
| muscleblind-like protein 1 isoform 1 | 4 | 0 | 0 | 4 |
| histone acetyltransferase KAT2A isoform 1 | 5 | 0 | 0 | 5 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| lethal factor (plasmid) | 2 | 0 | 0 | 2 |
| lamin isoform A-delta10 | 15 | 0 | 0 | 15 |
| Gamma-aminobutyric acid receptor subunit pi | 5 | 0 | 0 | 5 |
| Telomerase reverse transcriptase | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 1 | 1 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme ScaI | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-2-alpha | 0 | 1 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 2 | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-1 | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme PstI | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme EcoRI | 0 | 1 | 0 | 1 |
| Prothrombin | 0 | 0 | 0 | 1 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Interferon beta | 13 | 0 | 0 | 13 |
| Integrin beta-3 | 3 | 0 | 0 | 3 |
| Integrin alpha-IIb | 3 | 0 | 0 | 3 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 1 | 6 |
| DNA topoisomerase 2-alpha | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 5 | 0 | 0 | 5 |
| Type-2 restriction enzyme BamHI | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 5 | 0 | 0 | 5 |
| Somatostatin receptor type 1 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| Type-2 restriction enzyme HindIII | 0 | 1 | 0 | 1 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 5 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 5 | 0 | 0 | 5 |
| Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
| DNA topoisomerase 2-beta | 0 | 0 | 0 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| GABA theta subunit | 5 | 0 | 0 | 5 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 5 | 0 | 0 | 5 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 6 | 0 | 0 | 6 |
| RAR-related orphan receptor gamma | 14 | 0 | 0 | 14 |
| SMAD family member 2 | 10 | 0 | 0 | 10 |
| USP1 protein, partial | 8 | 0 | 0 | 8 |
| SMAD family member 3 | 10 | 0 | 0 | 10 |
| GLI family zinc finger 3 | 14 | 0 | 0 | 14 |
| Microtubule-associated protein tau | 8 | 0 | 0 | 8 |
| caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
| estrogen receptor 2 (ER beta) | 12 | 0 | 0 | 12 |
| nuclear receptor subfamily 1, group I, member 3 | 13 | 0 | 0 | 13 |
| progesterone receptor | 14 | 0 | 0 | 14 |
| retinoic acid nuclear receptor alpha variant 1 | 15 | 0 | 0 | 15 |
| retinoid X nuclear receptor alpha | 14 | 0 | 0 | 14 |
| farnesoid X nuclear receptor | 12 | 0 | 0 | 12 |
| peroxisome proliferator-activated receptor delta | 14 | 0 | 0 | 14 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 9 | 0 | 0 | 9 |
| caspase-3 | 4 | 0 | 0 | 4 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 9 | 0 | 0 | 9 |
| activating transcription factor 6 | 8 | 0 | 0 | 8 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 10 | 0 | 0 | 10 |
| thyroid hormone receptor beta isoform 2 | 15 | 0 | 0 | 15 |
| heat shock protein beta-1 | 4 | 0 | 0 | 4 |
| mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 16 | 0 | 0 | 16 |
| Voltage-dependent calcium channel gamma-2 subunit | 9 | 0 | 0 | 9 |
| Glutamate receptor 2 | 9 | 0 | 0 | 9 |
| Caspase-2 | 0 | 0 | 1 | 1 |
| ATPase family AAA domain-containing protein 5 | 9 | 0 | 0 | 9 |
| Ataxin-2 | 9 | 0 | 0 | 9 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 10 | 0 | 0 | 10 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 4 | 0 | 0 | 4 |
| thioredoxin glutathione reductase | 3 | 0 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 10 | 0 | 0 | 10 |
| pregnane X nuclear receptor | 12 | 0 | 0 | 12 |
| G | 9 | 0 | 0 | 9 |
| bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
| thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
| nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
| thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 5 | 0 | 0 | 5 |
| transcriptional regulator ERG isoform 3 | 4 | 0 | 0 | 4 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| peripheral myelin protein 22 | 10 | 0 | 0 | 10 |
| neuropeptide S receptor isoform A | 5 | 0 | 0 | 5 |
| HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
| Glucocorticoid receptor | 1 | 8 | 3 | 14 |
| Glycine receptor subunit alpha-1 | 0 | 8 | 0 | 8 |
| Androgen receptor | 0 | 12 | 0 | 12 |
| Glycine receptor subunit beta | 0 | 8 | 0 | 8 |
| Glycine receptor subunit alpha-2 | 0 | 8 | 0 | 8 |
| Glycine receptor subunit alpha-3 | 0 | 8 | 0 | 8 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 6 | 0 | 0 | 6 |
| Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
| cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
| Chain A, Beta-lactamase | 7 | 0 | 0 | 7 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| Smad3 | 3 | 0 | 0 | 3 |
| aryl hydrocarbon receptor | 4 | 0 | 0 | 4 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 3 | 0 | 0 | 3 |
| Progesterone receptor | 0 | 5 | 3 | 10 |
| Androgen receptor | 1 | 6 | 3 | 10 |
| Adenosine receptor A1 | 0 | 2 | 1 | 3 |
| Adenosine receptor A2b | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 1 | 1 | 2 |
| Mu-type opioid receptor | 0 | 6 | 1 | 8 |
| Nuclear receptor ROR-gamma | 3 | 0 | 0 | 3 |
| ORF73 | 0 | 0 | 1 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 2 | 0 | 0 | 2 |
| interleukin 8 | 4 | 0 | 0 | 4 |
| RAD51 | 0 | 1 | 0 | 1 |
| Histone H2A.x | 9 | 0 | 0 | 9 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 3 | 0 | 0 | 3 |
| caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 2 |
| Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | 0 | 1 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Discoidin domain-containing receptor 2 | 0 | 1 | 0 | 1 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
| Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 2 | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 4 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 2 | 5 |
| Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
| Prostaglandin F2-alpha receptor | 0 | 2 | 2 | 4 |
| Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 2 | 5 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
| Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
| Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 4 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 3 |
| Solute carrier family 22 member 8 | 0 | 2 | 0 | 5 |
| Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 3 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 2 |
| prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
| Cytochrome P450 3A4 | 0 | 3 | 2 | 5 |
| Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
| Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
| Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 3 | 0 | 0 | 3 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| chaperonin-containing TCP-1 beta subunit homolog | 3 | 0 | 0 | 3 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| IDH1 | 7 | 0 | 0 | 7 |
| ubiquitin-conjugating enzyme E2 N | 0 | 1 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Estrogen receptor | 1 | 7 | 2 | 10 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member B1 | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 1 | 3 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 3 | 0 | 3 |
| Alpha-2B adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 1 | 5 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-synuclein | 3 | 0 | 0 | 3 |
| Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 6 | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 5 | 0 | 5 |
| Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Luciferase | 2 | 0 | 0 | 2 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| nonstructural protein 1 | 4 | 0 | 0 | 4 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 5 | 0 | 0 | 5 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| Vpr | 2 | 0 | 0 | 2 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 3 |
| Amyloid-beta precursor protein | 1 | 1 | 0 | 2 |
| Thymidylate synthase | 0 | 3 | 0 | 3 |
| Aromatase | 0 | 1 | 0 | 1 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 1 | 3 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 1 | 3 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 1 | 3 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 1 | 3 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 1 | 3 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 2 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 1 | 3 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 4 | 0 | 0 | 4 |
| GLS protein | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 3 | 0 | 3 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 2 | 0 | 0 | 2 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| TAR DNA-binding protein 43 | 3 | 0 | 0 | 3 |
| PINK1 | 1 | 0 | 0 | 1 |
| Parkin | 1 | 0 | 0 | 1 |
| Sex hormone-binding globulin | 0 | 0 | 2 | 2 |
| Mineralocorticoid receptor | 1 | 3 | 1 | 6 |
| Androgen receptor | 0 | 0 | 1 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Guanine nucleotide-binding protein G | 4 | 0 | 0 | 4 |
| Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 1 | 3 | 2 | 6 |
| cystic fibrosis transmembrane conductance regulator ATP-binding cassette sub-family C member 7 | 0 | 0 | 0 | 2 |
| cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
| Cannabinoid receptor 1 | 0 | 2 | 0 | 2 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 4 | 0 | 0 | 4 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| ClpP | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 3 | 0 | 3 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 2 | 0 | 2 | 1 | 3 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 2 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 1 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 3 | 1 | 5 |
| Mu-type opioid receptor | 0 | 3 | 1 | 7 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 5 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 0 | 0 | 1 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| T cell receptor, partial | 1 | 0 | 0 | 1 |
| luteinizing hormone receptor | 1 | 0 | 0 | 1 |
| integrase, partial | 0 | 1 | 0 | 1 |
| lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
| Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
| TSHR protein | 1 | 0 | 0 | 1 |
| Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
| hypothetical protein, conserved | 2 | 0 | 0 | 2 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| luciferase | 1 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
| neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
| caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
| replicative DNA helicase | 0 | 0 | 0 | 1 |
| recombinase A | 0 | 0 | 1 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 1 | 0 | 2 |
| Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 0 | 1 |
| Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
| Microtubule-associated protein tau | 0 | 1 | 1 | 2 |
| Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Cruzipain | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 2 |
| Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| Chain A, PROGESTERONE RECEPTOR | 0 | 1 | 0 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Tegument protein VP16 | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 1 | 3 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| Coagulation factor VII | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 2 | 0 | 2 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 1 | 2 |
| Substance-P receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 4 | 1 | 6 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 1 | 0 | 1 |
| Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Opioid receptor homologue | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M3 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M5 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
| Translocator protein | 0 | 0 | 1 | 1 |
| Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 2 | 1 | 4 |
| UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 2 | 1 | 4 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 3 |
| Mu-type opioid receptor | 0 | 2 | 1 | 5 |
| Nociceptin receptor | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
| Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 2 | 2 | 4 |
| Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
| Vasopressin V1a receptor | 0 | 2 | 1 | 3 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
| Oxytocin receptor | 0 | 1 | 0 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 2 | 2 |
| Solute carrier family 22 member 6 | 0 | 2 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase 1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase SHV-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase OXA-10 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
| Beta-lactamase TEM | 0 | 1 | 0 | 2 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Efflux transporter | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Class D beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Metallo-b-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase IMP-1 | 0 | 0 | 0 | 1 |
| BlaVIM-1 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
| Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 1 |
| Beta-lactamase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
| Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 12 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 1 | 2 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Carbonic anhydrase 3 | 0 | 1 | 0 | 1 |
| Stromelysin-1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
| Estrogen receptor | 0 | 0 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
| Carbonic anhydrase 14 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Chain A, PLASMINOGEN | 0 | 0 | 1 | 1 |
| Plasminogen | 0 | 2 | 1 | 3 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Urease subunit alpha | 0 | 1 | 0 | 1 |
| Urease subunit beta | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
| Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |